Top Markets
#1 Akedo Akedo +54.06%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.26%
#4 Cross Cross +47.18%
#5 Black Phoenix Black Phoenix +34.15%
#6 Velvet Velvet +31.77%
#7 OVERTAKE OVERTAKE +18.70%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.05%
#9 Movement Movement +13.43%
#10 Perle Perle +11.98%
Coin of the day
Akedo Akedo
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
RepliCel Life Sciences Inc. RepliCel Life Sciences Inc.

RepliCel Life Sciences Inc.

RP
Classement en actions #38777
Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a... Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a regenerative medicine company dedicated to developing innovative autologous cell therapies. These treatments are designed to correct functional cellular deficiencies by harnessing a patient's own cells. The process involves isolating cells from harvested tissues, significantly expanding them in a controlled laboratory environment, and subsequently applying them therapeutically. The company's developmental portfolio includes several key product candidates: RCT-01 targets chronic tendinosis, RCS-01 addresses aging and sun-damaged skin, and RCH-01 is aimed at treating hair loss. Additionally, RepliCel is advancing RCI-02, a specialized dermal injection device. RepliCel has established significant strategic alliances. It holds a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. to establish a clinical research program and facilitate the commercialization of RCS-01 and RCT-01. A similar collaboration exists with Shiseido Company, Limited, focusing on the clinical research program for RCH-01. Furthermore, the company is engaged in a research project agreement with the University of British Columbia, contributing to the creation of a comprehensive hair follicle cell data map.
Prix de l'action
$0.01100905
Dernière synchronisation: 2025-02-28
Capitalisation boursière
$810.02K
Changement (1 jour)
58.98%
Changement (1 an)
0.00%
Pays
CA
Échange RepliCel Life Sciences Inc. (RP)

Catégorie

Healthcare
Le prix RP avec la capitalisation boursière de B
RepliCel Life Sciences Inc. RepliCel Life Sciences Inc.
RP
$0.01100905
Capitalisation boursière de RepliCel Life Sciences Inc.(RP)
Capitalisation boursière: $810.02K
En August 2026, RepliCel Life Sciences Inc. a une capitalisation boursière de $810.02K. Cela fait de RepliCel Life Sciences Inc. la 38777th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de RepliCel Life Sciences Inc. du 2014 au 2026
RP par rapport au top 5 des plus populaires stocks
Prix pour RP L’actif B La capitalisation boursière de B Résultats
RepliCel Life Sciences Inc. RepliCel Life Sciences Inc.
$74,115.58 $810.02K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.453T +673,223,809.47%
RepliCel Life Sciences Inc. RepliCel Life Sciences Inc.
$60,970.12 $810.02K
Apple Inc. Apple Inc.
AAPL
$4.486T +553,817,905.77%
RepliCel Life Sciences Inc. RepliCel Life Sciences Inc.
$56,581.75 $810.02K
Alphabet Inc. Alphabet Inc.
GOOG
$4.163T +513,956,440.19%
RepliCel Life Sciences Inc. RepliCel Life Sciences Inc.
$50,167.86 $810.02K
Microsoft Corporation Microsoft Corporation
MSFT
$3.691T +455,696,319.38%
RepliCel Life Sciences Inc. RepliCel Life Sciences Inc.
$38,639.45 $810.02K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.843T +350,978,769.42%